SCHEMBL20580211

SCHEMBL20580211

CCOC(=O)c1nc(-c2cccnc2)sc1N1CCOCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
KDM4E B2RXH2 5/20 0.52
CDC7 O00311 2/20 0.52
DBF4 Q9UBU7 2/20 0.52
MTOR P42345 2/20 0.49
L3MBTL1 Q9Y468 3/20 0.48
RECQL P46063 1/20 0.48
POLB P06746 2/20 0.47
PIK3CA P42336 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 2/20 0.46
NPC1 O15118 1/20 0.46
NFKB1 P19838 1/20 0.46
RAB9A P51151 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
IRAK4 Q9NWZ3 2/20 0.45
RXFP1 Q9HBX9 1/20 0.45
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21024951 0.82 IRAK4 (0.52) MTORPIK3CAIRAK4LMNASMN1; SMN2
SCHEMBL18394735 0.82 KDM4E (0.46) ALDH1A1KDM4EMTORL3MBTL1PIK3CA
SCHEMBL18394475 0.81 USP2 (0.44) ALDH1A1KDM4EMTORL3MBTL1RECQL
SCHEMBL18395300 0.80 ALDH1A1 (0.51) ALDH1A1KDM4EMTORL3MBTL1RECQL
SCHEMBL29664456 0.80 ALDH1A1 (0.51) ALDH1A1KDM4EMTORL3MBTL1RECQL
SCHEMBL20022399 0.79 CDC7 (0.62) ALDH1A1KDM4ECDC7DBF4POLB
SCHEMBL2080239 0.79 MEN1 (0.54) ALDH1A1KDM4ECDC7DBF4L3MBTL1
SCHEMBL289392 0.77 CDC7 (0.60) ALDH1A1KDM4ECDC7DBF4POLB
SCHEMBL289684 0.77 CDC7 (0.60) ALDH1A1KDM4ECDC7DBF4POLB
SCHEMBL18394360 0.77 L3MBTL1 (0.46) ALDH1A1KDM4EMTORL3MBTL1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10752598-B2 Aryldiazepine derivatives as RSV inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2020-08-25 US disclosed
US-10752598-B2 Aryldiazepine derivatives as RSV inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2020-08-25 US disclosed
US-10647711-B2 Azepin-2-one derivatives as RSV inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2020-05-12 US disclosed
US-10647711-B2 Azepin-2-one derivatives as RSV inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2020-05-12 US disclosed
US-20190152968-A1 AZEPIN-2-ONE DERIVATIVES AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. 2019-05-23 US disclosed
US-20190152968-A1 AZEPIN-2-ONE DERIVATIVES AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. 2019-05-23 US disclosed
WO-2018226801-A1 ARYLDIAZEPINE DERIVATIVES AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2018-12-13 WO disclosed
US-20180354912-A1 ARYLDIAZEPINE DERIVATIVES AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. 2018-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180354912-A1 ARYLDIAZEPINE DERIVATIVES AS RSV INHIBITORS AHR, FURIN, CYP3A5 ALDH1A1 375/4885KDM4E 544/4885CDC7 4472/4885
US-20190152968-A1 AZEPIN-2-ONE DERIVATIVES AS RSV INHIBITORS AZI2, FURIN, ACE2 ALDH1A1 1328/4885KDM4E 892/4885CDC7 4202/4885
US-10647711-B2 Azepin-2-one derivatives as RSV inhibitors AZI2, FURIN, ACE2 ALDH1A1 1328/4885KDM4E 892/4885CDC7 4202/4885
US-10752598-B2 Aryldiazepine derivatives as RSV inhibitors AHR, FURIN, CYP3A5 ALDH1A1 375/4885KDM4E 544/4885CDC7 4472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.